TuHURA Biosciences, Inc./NV Cash And Cash Equivalents At Carrying Value

• TuHURA Biosciences, Inc./NV showed a decrease of -71.4% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from TuHURA Biosciences, Inc./NV's annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2010 to 2025 (19 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 19 years of available data (2010 to 2025), TuHURA Biosciences, Inc./NV's Cash And Cash Equivalents At Carrying Value has grown by 14,751.1%.
• Historical annual values: Fiscal year 2025: $3.62 million | Fiscal year 2024: $12.66 million | Fiscal year 2024: $4.91 million | Fiscal year 2023: $3.67 million | Fiscal year 2023: $1.54 million | Fiscal year 2022: $11.78 million | Fiscal year 2021: $10.54 million | Fiscal year 2020: $2.39 million | Fiscal year 2019: $3.72 million | Fiscal year 2018: $5.97 million | Fiscal year 2017: $6.59 million | Fiscal year 2016: $6.16 million | Fiscal year 2015: $1.75 million | Fiscal year 2014: $4.76 million | Fiscal year 2013: $4.14 million | Fiscal year 2013: $6.28 million | Fiscal year 2012: $17.8 thousand | Fiscal year 2011: $15.0 thousand | Fiscal year 2010: $24.4 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026